EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases

Rui-Ming Liu iD, Mary F Nakamya

Cells · 19.03.2026 · 15 (6) · 551

DOI: 10.3390/cells15060551 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, online erschienen am 19.03.2026. Verfasst von Rui-Ming Liu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, School of Medicine, University of Alabama at Birmingham, 1900 University B…. Hauptthemen laut MEDLINE: Cellular Senescence, Plasminogen Activator Inhibitor 1, Aging. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 355 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH/NIA, NIA NIH HHS, University of Alabama at Birmingham School of Medicine.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cellular senescence, including replicative senescence (RS) and stress-induced premature senescence (SIPS), is a state of the permanent arrest of cell growth, which can occur in proliferative cells and post-mitotic cells. Cellular senescence is believed to contribute importantly to aging and aging-related diseases. Although several hypotheses, including telomere shortening, oncogene activation, oxidative stress, DNA damage, and mitochondrial dysfunction, have been proposed, the mechanisms underlying cellular senescence in either physiological or pathological conditions remain poorly understood. Plasminogen activator inhibitor 1 (PAI-1), a physiological inhibitor of tissue type and urokinase type of plasminogen activators (tPA and uPA), has multiple functions. PAI-1 expression increases with age and in many aging-related diseases. Importantly, increased PAI-1 expression is not only a marker but also a mediator of cell senescence induced by different stimuli in vitro and in vivo. This review focuses on the recent advance in the role of PAI-1 in cell senescence during aging and in aging-related diseases as well as the potential mechanisms by which PAI-1 promotes cell senescence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cellular SenescencePlasminogen Activator Inhibitor 1AgingHumansAnimals

Stichwörter der Autor:innen

PAI-1agingaging-related diseasescell senescence

Substanzen

Plasminogen Activator Inhibitor 1

Autor:innen und Institutionen

  • Division of Pulmonary, Allergy, and Critical Care, Department of Medicine, School of Medicine, University of Alabama at Birmingham, 1900 University Blvd., THT 541C, Birmingham, AL 35294-0006, USA.

ORCID-Profile: Rui-Ming Liu

Förderung

  • NIH/NIA
  • NIA NIH HHS
  • University of Alabama at Birmingham School of Medicine
  • Department of Defence
  • National Institutes of Health
  • National Institute of Aging to Rui-Ming Liu

Zitieren

APA

Liu, R. M., & Nakamya, M. F. (2026). Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases. Cells, 15(6), 551. https://doi.org/10.3390/cells15060551

Vancouver

Liu RM, Nakamya MF. Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases. Cells. 2026;15(6):551. doi:10.3390/cells15060551

BibTeX
@article{Liu2026,
  author = {Liu, Rui-Ming and Nakamya, Mary F},
  title = {Plasminogen Activator Inhibitor 1, Cell Senescence, and Aging-Related Diseases},
  journal = {Cells},
  year = {2026},
  volume = {15},
  number = {6},
  pages = {551},
  doi = {10.3390/cells15060551}
}
Kostenlos starten →